Automation, continuous manufacturing drive global pharmaceutical equipment demand

It is also driven by chronic diseases and biologics production.

The global pharmaceutical manufacturing equipment market is expected to grow from $21.24b in 2026 to $30.39b by 2032, according to MarketsandMarkets.

The report attributed the growth to rising production of branded generic biologics and increasing cases of chronic diseases, which are pushing drug manufacturers to expand output.

Broader healthcare access and higher demand for sterile injectables and vaccines are also supporting market expansion. Companies are adopting automation and continuous manufacturing technologies to improve efficiency and meet regulatory standards. Equipment upgrades and investment in high-potency medicines further support growth.

The packaging machines segment is projected to dominate the market. Packaging ensures product safety, labeling accuracy, and regulatory compliance.

Strict serialisation, tamper-evident rules, and anti-counterfeiting regulations are increasing demand for advanced, automated packaging systems. Growth in tablet and capsule production, exports, and contract manufacturing is also driving this segment.

Solid dosage forms—tablets, capsules, and powders—are expected to hold the largest share. These formats offer longer shelf life and easier storage, making them widely used.

Rising demand for oral medicines, especially for chronic diseases, and the expansion of generic drug manufacturing are increasing investment in granulation, tablet compression, coating, and capsule filling equipment. Manufacturers are focusing on high-speed production lines to boost output and reduce costs.